We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Indoleamine 2, 3-dioxygenase (IDO) increases during renal fibrogenesis and its inhibition potentiates TGF-β 1-induced epithelial to mesenchymal transition.
- Authors
Matheus, Luiz Henrique Gomes; Simão, Gislene Mendes; Amaral, Taíssa Altieri; Brito, Rodrigo Barbosa Oliveira; Malta, Camila Soares; Matos, Yves Silva Teles; Santana, Alexandre Chagas; Rodrigues, Gabriela Gomes Cardoso; Albejante, Maria Clara; Bach, Erna Elisabeth; Dalboni, Maria Aparecida; Camacho, Cleber Pinto; Dellê, Humberto
- Abstract
<bold>Background: </bold>Indoleamine 2, 3-dioxygenase (IDO) is an immunomodulatory molecule that has been implicated in several biological processes. Although IDO has been linked with some renal diseases, its role in renal fibrosis is still unclear. Because IDO may be modulated by TGF-β1, a potent fibrogenic molecule, we hypothesized that IDO could be involved in renal fibrosis, especially acting in the TGF-β1-induced tubular epithelial-mesenchymal transition (EMT). We analyzed the IDO expression and activity in a model of renal fibrogenesis, and the effect of the IDO inhibitor 1-methyl-tryptophan (MT) on TGF-β1-induced EMT using tubular cell culture.<bold>Methods: </bold>Male Wistar rats where submited to 7 days of UUO. Non-obstructed kidneys (CL) and kidneys from SHAM rats were used as controls. Masson's Tricrome and macrophages counting were used to chatacterize the tissue fibrosis. The EMT was analysed though immunohistochemistry and qRT-PCR. Immunohistochemestry in tissue has used to show IDO expression. MDCK cells were incubated with TGF- β1 to analyse IDO expression. Additionally, effects of TGF- β1 and the inhibition of IDO over the EMT process was acessed by immunoessays and scrath wound essay.<bold>Results: </bold>IDO was markedly expressed in cortical and medular tubules of the UUO kidneys. Similarly to the immunolocalizaton of TGF- β1, accompanied by loss of e-cadherin expression and an increase of mesenchymal markers. Results in vitro with MDCK cells, showed that IDO was increased after stimulus with TGF-β1, and treatment with MT potentiated its expression. MDCK stimulated with TGF-β1 had higher migratory activity (scratch-wound assay), which was exacerbated by MT treatment.<bold>Conclusions: </bold>IDO is constitutively expressed in tubular cells and increases during renal fibrogenesis. Although IDO is induced by TGF-β1 in tubular cells, its chemical inhibitor acts as a profibrotic agent.
- Publication
BMC Nephrology, 2017, Vol 18, Issue 1, p287
- ISSN
1471-2369
- Publication type
journal article
- DOI
10.1186/s12882-017-0702-7